CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its ...
The most common solicited systemic adverse events include headache, fatigue, myalgia and chills. Additional regulatory applications for Moderna’s updated COVID-19 vaccines targeting LP.8.1 are under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results